Biomaterials. 2012 Oct;33(29):6974-86. Epub 2012 Jul 11.
Abstract
Multipotent postnatal stem cells can be isolated
from human periodontal ligaments (PDLs) and have the potential for
large-scale expansion, offering a reliable cell source for clinical use
in periodontal regenerative therapies. However, the effects of aging on
the mesenchymal stem cell (MSC) properties of these cells remain
undefined. The aims of this study were to isolate and characterize the
periodontal ligament stem cells (PDLSCs) derived from human impacted
third molars of donors of different ages and to compare their
pluripotential capacity and regenerative potential. PDL tissues were
obtained from 90 surgically extracted third molars and divided into four
groups according to the donor's age. For each group, the colony-forming
ability, proliferative capacity, migratory potential, cell surface
antigens, differentiation ability, alkaline phosphatase activity, and
gene expression of the PDLSCs were contrastively evaluated and
quantified for statistical analysis. The in vivo tissue regenerative
potential of PDLSCs was assessed by an in vivo ectopic transplantation
model. It was found that human PDLSCs were successfully isolated and
characterized as MSCs in all 90 teeth. PDLSCs derived from donors of
different ages were successfully differentiated under an osteogenic and
adipogenic microenvironment. The proliferative and migratory potential
and the differentiation capacity of PDLSCs decreased as age increased
(p < 0.05). PDLSCs derived from donors whose age is 62.6 ± 6.8 have a
statistically significant decrease in pluripotential capacity compared
with those derived from relatively young donors (p < 0.01). There is
no identified cementum and PDL-like tissue formation in vivo among the
two aging groups. We conclude that human PDLSCs could be successfully
isolated from PDL tissue derived from donors of different ages, but the
age-related changes of the MSC properties should be taken into account
whenever they are intended for use in research or cytotherapy.
Comments